**建筑电工承包商；装灯、布线；汽车充电桩安装；照明故障维修；**
**电力安全检查/证书。**

加拿大政府出台第一阶段国家全民药保立法

《北美之声》创办人陈蓉编辑报道

源自：加拿大卫生部

立法包括普及避孕药具和糖尿病药物。

2024 年 2 月 29 日 – 安大略省渥太华

今天，卫生部长马克·霍兰（Mark Holland）阁下介绍了 C-64 号法案，即《药剂医保法》（Pharmacare Act），该法案提出了加拿大全国全民药剂医保第一阶段的基本原则，并描述了加拿大政府与各省和地区合作，为一些避孕和糖尿病药物提供全民单一支付者保险。

部长还宣布，政府计划设立一项基金，支持加拿大人获得糖尿病患者管理和监测病情以及用药所需的用品，如注射器和葡萄糖试纸。

这项立法是在改善医疗公平性、可负担性和结果方面迈出的重要一步，并有可能为医疗保健系统节省长期开支。

覆盖避孕药具将意味着 900 万育龄加拿大人将有更好的机会获得避孕药具和生育自主权，降低意外怀孕的风险，提高他们规划未来的能力。费用一直被认为是获得这些药物的最主要障碍，而妇女和不同性别的加拿大人承担的费用并不均衡。C-64 法案将确保加拿大人能够获得一整套避孕药物和装置。

糖尿病是一种无法治愈的复杂疾病，但可以通过安全有效的药物进行治疗。每四名加拿大糖尿病患者中就有一人表示，由于费用问题，他们没有按照治疗计划进行治疗。改善糖尿病药物的获取途径将有助于改善 370 万加拿大糖尿病患者的健康状况，降低失明或截肢等严重影响生活的健康并发症的风险。

在过去的一年里，加拿大政府采取了一些关键行动，在加拿大提供更好、更方便的医疗保健服务。经济障碍不应成为获得安全有效的处方药和相关产品的障碍。我们决心努力制定一项计划，让加拿大人无论居住在哪里或支付能力如何，都能按处方获得药物。

该法案表明，加拿大政府致力于就未来发展方向进行广泛磋商，并与各省、地区、土著人民及其他合作伙伴和利益相关方合作，通过减少经济障碍和促进身心健康和福祉，改善药品的可获得性、可负担性和适当使用。

C-64 法案还规定，新成立的加拿大药品管理局应努力制定国家处方集，制定国家大宗采购战略，并支持发布关于适当使用处方药的泛加拿大战略。

这些要素将共同构成加拿大实现国家全民药保的关键性下一步措施。部长将进一步成立一个专家委员会，就加拿大全国性、全民性、单一支付者药剂保险的运作和筹资问题提出建议。

C-64 法案建议对我们的医疗保健格局进行重大改革，该法案以及从《罕见病药物国家战略》和爱德华王子岛省《改善处方药可负担性倡议》等现行倡议中汲取的经验，是加拿大政府确保加拿大人能够获得所需药品的计划的一部分，并为在加拿大实施全国全民药保铺平了道路。

引述

"每个加拿大人都应该能够获得所需的处方药。这就是为什么我们正在与我们的合作伙伴一起努力，争取实现全国全民药保的第一阶段。这一重要的下一步将普及避孕药具和糖尿病药物，这将对改善加拿大的健康状况产生深远影响"。

-马克·霍兰阁下卫生部长

事实简要

• 2023 年 12 月 18 日，加拿大政府宣布成立加拿大药物管理局，从 2024-25 年开始，5 年内投资超过 8950 万加元。该机构将提供必要的专门领导和协调，使加拿大的药物系统更具可持续性，为未来做好准备，并帮助加拿大人实现更好的健康结果。

• 2023 年 3 月 22 日，加拿大政府宣布了支持有史以来首个《罕见病药物国家战略》的措施，将在三年内投资高达 15 亿加元，以帮助提高罕见病有效药物的可及性和可负担性。 C-64 法案承诺采用长期资助模式，首先为国家罕见病药物战略提供资金，并主要通过与各省和地区的双边协议提供。

• 爱德华王子岛居民在 2023 年 6 月启动的爱德华王子岛 5 元共付额计划下，已为 23 万多张处方节省了 200 多万加元的自付费用，该计划降低了近 60% 岛民经常使用的药物的共付额。这些最新改进是 "改善处方药的可负担性"（IAAPD）倡议的一个重要里程碑，该倡议向爱德华王子岛提供联邦资金，以改善处方药的可负担性，并使该岛居民更能负担得起处方药。

相关链接

• Backgrounder: Universal Access to Contraception • Backgrounder: Universal Access to Diabetes Medications, and Diabetes Device Fund for Devices and Supplies

• Final Report of the Advisory Council on the Implementation of National Pharmacare

• Prescription drug insurance coverage

联络

Christopher Aoun

Press Secretary

Office of the Honourable Mark Holland

Minister of Health

613-291-4176

Media Relations

Health Canada and Public Health Agency of Canada

613-957-2983

media@hc-sc.gc.ca

Public Inquiries:

613-957-2991

1-866-225-0709

Government of Canada Introduces Legislation for First Phase of National Universal Pharmacare

From: Health Canada

News release

Legislation includes universal access to contraception and diabetes medications.

February 29, 2024 | Ottawa, Ontario | Health Canada

Today, the Honourable Mark Holland, Minister of Health, introduced Bill C-64, An Act respecting pharmacare (Pharmacare Act), which proposes the foundational principles for first phase of national universal pharmacare in Canada and describes the Government of Canada’s intent to work with provinces and territories (PTs) to provide universal, single-payer coverage for a number of contraception and diabetes medications.

The Minister also announced the government’s plan to establish a fund to support Canadians’ access to supplies that diabetics require to manage and monitor their condition and administer their medication, such as syringes and glucose test strips.

This legislation is an important step forward to improve health equity, affordability, and outcomes and has the potential of longterm savings to the health care system. Coverage for contraceptives will mean that 9 million Canadians of reproductive age will have better access to contraception and reproductive autonomy, reducing the risk of unintended pregnancies and improving their ability to plan for the future. Cost has consistently been identified as the single most important barrier to access to these medications and the cost is unevenly borne by women and gender diverse Canadians. Bill C-64 will ensure that Canadians will have access to a comprehensive suite of contraceptive drugs and devices.

Diabetes is a complex disease that has no cure but can be treated with safe and effective medications. One in four Canadians with diabetes have reported not following their treatment plan due to cost. Improving access to diabetes medications will help improve the health of 3.7 million Canadians living with diabetes and reduce the risk of serious life-changing health complications such as blindness or amputations.

Over the past year, the Government of Canada has delivered on key actions to provide better and more accessible health care in Canada. Financial barriers should not be an impediment to accessing safe and effective prescription drugs and related products. We are determined to work towards a plan where Canadians can obtain their medication as prescribed, regardless of where they live or their ability to pay.

The Bill demonstrates the Government of Canada’s commitment to consulting widely about the way forward and working with provinces, territories, Indigenous peoples and other partners and stakeholders to improve the accessibility, affordability and appropriate use of pharmaceutical products, by reducing financial barriers and contributing to physical and mental health and wellbeing.

Bill C-64 also provides that the new Canadian Drug Agency work towards the development of a national formulary, develop a national bulk purchasing strategy, and support the publication of a pan-Canadian strategy regarding the appropriate use of prescription medications. Together, these elements would form the key next steps towards national universal pharmacare in Canada. The Minister would further establish a committee of experts to make recommendations on the operation and financing of national, universal, single-payer pharmacare in Canada. Bill C-64 proposes a significant change to our heath care landscape, which, together with the learnings from ongoing initiatives such as the National Strategy for Drugs for Rare Diseases and the Improving Affordable Access to Prescriptions Drugs initiative with Prince Edward Island, are part of the Government of Canada’s plan to ensure Canadians can access the medicines they need and pave the way forward towards the implementation of national universal pharmacare in Canada.

Quotes

“Each and every Canadian should have access to the prescription drugs they need. That’s why we’re working with our partners towards the first phase of national universal pharmacare. This important next step will provide universal access to contraception and diabetes medication that will be transformational in improving health outcomes in Canada.”

The Honourable Mark Holland Minister of Health

Quick facts

• On December 18, 2023, the Government of Canada announced the creation of the Canadian Drug Agency with an investment of over $89.5 million over 5 years, starting in 2024-25. The Agency will provide the dedicated leadership and coordination needed to make Canada’s drug system more sustainable and prepared for the future and help Canadians achieve better health outcomes.

• On March 22 2023, the Government of Canada announced measures in support of the first-ever National Strategy for Drugs for Rare Diseases, with an investment of up to $1.5 billion over three years to help increase access to, and the affordability of, effective drugs for rare diseases. Bill C-64 commits to a model for long-term funding, beginning with funding for the National Strategy for Drugs for Rare Diseases and to be primarily provided through bilateral agreements with provinces and territories.

• PEI residents have saved over $2 million in out-of-pocket costs on more than 230,000 prescriptions under PEI’s $5 copay program, which was launched in June 2023 and reduced copays for almost 60% of medications regularly used by Island residents. These latest improvements are an important milestone of the Improving Affordable Access to Prescriptions Drugs (IAAPD) initiative that provides federal funding to PEI to improve access to prescription drugs and make prescriptions drugs more affordable for Island residents.

Associated links

• Backgrounder: Universal Access to Contraception

• Backgrounder: Universal Access to Diabetes Medications, and Diabetes Device Fund for Devices and Supplies

• Final Report of the Advisory Council on the Implementation of National Pharmacare

• Prescription drug insurance coverage

Contacts

Christopher Aoun

Press Secretary Office of the Honourable Mark Holland

Minister of Health

613-291-4176

Media Relations

Health Canada and Public Health Agency of Canada

613-957-2983

media@hc-sc.gc.ca

Public Inquiries:

613-957-2991

1-866-225-0709

—————————————————-

《北美之声》加拿大政府出台第一阶段国家全民药保立法

总理在国际妇女节的致辞

《北美之声》“四季艺术中心”成立庆典，合唱团迎春开班